Glioblastoma News and Research

RSS
Glioblastoma is the most aggressive and malignant form of glioma, a type of primary brain cancer. Surgery is often used to treat gliomas, along with radiation. However, since surgery and radiation fail to cure the disease, doctors may turn to additional radiation or chemotherapy. In early stages glioblastoma tumors often grow without symptoms and therefore can become quite large before symptoms arise. When the tumor becomes symptomatic, tumor growth is usually very rapid and is accompanied by altered brain function, and if left untreated the disease becomes lethal. Although primary treatment is often successful in temporarily stopping the progression of the tumor, glioblastomas almost always recur and become lethal.
Novel ‘gene therapy in a box’ could effectively deliver modified blood stem cells

Novel ‘gene therapy in a box’ could effectively deliver modified blood stem cells

Researchers develop MRI-based method that can track progression of genetically mutated gliomas

Researchers develop MRI-based method that can track progression of genetically mutated gliomas

UPV participates in Lumiblast project to develop novel treatments for hard-to-treat brain tumours

UPV participates in Lumiblast project to develop novel treatments for hard-to-treat brain tumours

CarThera receives €5.7 million grant for DOME project from France’s Investments for the Future Program

CarThera receives €5.7 million grant for DOME project from France’s Investments for the Future Program

Imran Noorani receives Brainlab Community Neurosurgery Abstract Award at 2016 CNS annual meeting

Imran Noorani receives Brainlab Community Neurosurgery Abstract Award at 2016 CNS annual meeting

University of Bonn researchers develop new method to combat complex brain tumors

University of Bonn researchers develop new method to combat complex brain tumors

Scientists discover potential way of stopping most aggressive brain tumour

Scientists discover potential way of stopping most aggressive brain tumour

Researchers use computer modelling to identify mechanism behind aggressive brain tumours

Researchers use computer modelling to identify mechanism behind aggressive brain tumours

Novel marine natural product appears to reduce pancreatic tumor size

Novel marine natural product appears to reduce pancreatic tumor size

Wistar scientists discover novel mechanism that helps tumors adapt to hypoxia

Wistar scientists discover novel mechanism that helps tumors adapt to hypoxia

Lack of insurance may increase risk of death in men with testicular cancer, study finds

Lack of insurance may increase risk of death in men with testicular cancer, study finds

Studies show insurance status may impact patients' health outcomes following cancer diagnosis

Studies show insurance status may impact patients' health outcomes following cancer diagnosis

UCLA researchers develop new combination therapy to activate immune response against glioblastoma

UCLA researchers develop new combination therapy to activate immune response against glioblastoma

Combined therapy approach could prove promising to treat brain cancer

Combined therapy approach could prove promising to treat brain cancer

Yale-led study shows how EGFR silences tumor suppressor genes

Yale-led study shows how EGFR silences tumor suppressor genes

Researchers seek to develop novel antibody to treat glioblastoma

Researchers seek to develop novel antibody to treat glioblastoma

Scientific paper supports concept of CarThera's intracranial ultrasound implant to disrupt blood-brain barrier

Scientific paper supports concept of CarThera's intracranial ultrasound implant to disrupt blood-brain barrier

Four miRNAs may hold vital clue to disease progression in gliobastoma

Four miRNAs may hold vital clue to disease progression in gliobastoma

New nano-fabricated platform provides accurate post-surgery prognosis for glioblastoma patients

New nano-fabricated platform provides accurate post-surgery prognosis for glioblastoma patients

Study underscores importance of developing PRMT5 inhibitors as promising treatment for GB patients

Study underscores importance of developing PRMT5 inhibitors as promising treatment for GB patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.